DocGo Inc’s recently made public that its Director KATZ STEVEN acquired Company’s shares for reported $49140.0 on Mar 15 ’24. In the deal valued at $3.64 per share,13,500 shares were bought. As a result of this transaction, KATZ STEVEN now holds 69,534 shares worth roughly $0.23 million.
Then, ROSENBERG NORMAN bought 10,000 shares, generating $36,100 in total proceeds. Upon buying the shares at $3.61, the CFO and Treasurer now owns 274,222 shares.
Before that, Burdiek Michael J bought 10,000 shares. DocGo Inc shares valued at $36,100 were divested by the Director at a price of $3.61 per share. As a result of the transaction, Burdiek Michael J now holds 571,595 shares, worth roughly $1.86 million.
BTIG Research initiated its DocGo Inc [DCGO] rating to a Buy in a research note published on August 18, 2023; the price target was $15. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Deutsche Bank began covering DCGO with “Buy” recommendation on April 19, 2022. Stifel started covering the stock on January 19, 2022. It rated DCGO as “a Buy”.
Price Performance Review of DCGO
On Monday, DocGo Inc [NASDAQ:DCGO] saw its stock fall -0.31% to $3.25. Over the last five days, the stock has lost -14.02%. DocGo Inc shares have fallen nearly -41.86% since the year began. Nevertheless, the stocks have fallen -61.31% over the past one year. While a 52-week high of $10.82 was reached on 01/02/24, a 52-week low of $2.78 was recorded on 01/10/24. SMA at 50 days reached $3.71, while 200 days put it at $5.81. A total of 1.07 million shares were traded, compared to the trading of 0.69 million shares in the previous session.
Levels Of Support And Resistance For DCGO Stock
The 24-hour chart illustrates a support level at 3.19, which if violated will result in even more drops to 3.13. On the upside, there is a resistance level at 3.29. A further resistance level may holdings at 3.33. The Relative Strength Index (RSI) on the 14-day chart is 32.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.01%. Stochastics %K at 33.88% indicates the stock is a holding.
The most recent change occurred on December 21, 2021 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
